Modulation of NMDA- and (+)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord

Yoshinori Yajima, Minoru Narita, Makoto Tsuda, Satoshi Imai, Junzo Kamei, Hiroshi Nagase, Tsutomu Suzuki

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The present study was designed to investigate the effect of a selective GABAB receptor agonist baclofen on the pain-like nociceptive behavior (scratching, biting and licking) induced by intrathecal (i.t.) injection of N-methyl-D-aspartate (NMDA) or (+)TAN-67, the enantiomorphs of 2-methyl-4aα-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12aα-octahydro-qui nolino[2,3,3g]isoquinoline (TAN-67), in the mouse. NMDA (0.05-0.2 μg/mouse) given i.t. immediately caused nociception in a dose-dependent manner. The nociception was significantly antagonized by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse), a non-competitive NMDA receptor antagonist. I.t. co-injection with baclofen (37.5-150 ng/mouse) significantly reduced the NMDA-induced nociceptive behavior in a dose-dependent fashion. The inhibition produced by baclofen was completely reversed by a selective GABAB receptor antagonist 2-hydroxysaclofen (0.15 and 0.3 μg/mouse). An i.t. injection of (+)TAN-67 at doses of 3.75-15 μg/mouse elicited a long-lasting and a dose-related nociception. The nociceptive behavior induced by (+)TAN-67 given i.t. was markedly suppressed by i.t. co-injection with baclofen (3-30 ng/mouse), and the inhibitory effect of baclofen was prevented by i.t. injection of 2-hydroxysaclofen (1 and 3 μg/mouse). In addition, the (+)TAN-67-induced nociception was also attenuated by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse). These results suggest that spinal GABAB receptors may be implicated in the expression of nociception elicited by i.t. injection of either NMDA or (+)TAN-67 in the mouse.

Original languageEnglish
Pages (from-to)719-725
Number of pages7
JournalLife Sciences
Volume68
Issue number6
DOIs
Publication statusPublished - Dec 29 2000
Externally publishedYes

Fingerprint

Nociception
N-Methylaspartate
Baclofen
Spinal Injections
Spinal Cord
Modulation
N-Methyl-D-Aspartate Receptors
TAN 67
GABA-B Receptors
Nociceptive Pain
Injections

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Modulation of NMDA- and (+)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord. / Yajima, Yoshinori; Narita, Minoru; Tsuda, Makoto; Imai, Satoshi; Kamei, Junzo; Nagase, Hiroshi; Suzuki, Tsutomu.

In: Life Sciences, Vol. 68, No. 6, 29.12.2000, p. 719-725.

Research output: Contribution to journalArticle

Yajima, Yoshinori ; Narita, Minoru ; Tsuda, Makoto ; Imai, Satoshi ; Kamei, Junzo ; Nagase, Hiroshi ; Suzuki, Tsutomu. / Modulation of NMDA- and (+)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord. In: Life Sciences. 2000 ; Vol. 68, No. 6. pp. 719-725.
@article{c2b6f555efd14d37b2f97eb0ef0a133a,
title = "Modulation of NMDA- and (+)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord",
abstract = "The present study was designed to investigate the effect of a selective GABAB receptor agonist baclofen on the pain-like nociceptive behavior (scratching, biting and licking) induced by intrathecal (i.t.) injection of N-methyl-D-aspartate (NMDA) or (+)TAN-67, the enantiomorphs of 2-methyl-4aα-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12aα-octahydro-qui nolino[2,3,3g]isoquinoline (TAN-67), in the mouse. NMDA (0.05-0.2 μg/mouse) given i.t. immediately caused nociception in a dose-dependent manner. The nociception was significantly antagonized by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse), a non-competitive NMDA receptor antagonist. I.t. co-injection with baclofen (37.5-150 ng/mouse) significantly reduced the NMDA-induced nociceptive behavior in a dose-dependent fashion. The inhibition produced by baclofen was completely reversed by a selective GABAB receptor antagonist 2-hydroxysaclofen (0.15 and 0.3 μg/mouse). An i.t. injection of (+)TAN-67 at doses of 3.75-15 μg/mouse elicited a long-lasting and a dose-related nociception. The nociceptive behavior induced by (+)TAN-67 given i.t. was markedly suppressed by i.t. co-injection with baclofen (3-30 ng/mouse), and the inhibitory effect of baclofen was prevented by i.t. injection of 2-hydroxysaclofen (1 and 3 μg/mouse). In addition, the (+)TAN-67-induced nociception was also attenuated by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse). These results suggest that spinal GABAB receptors may be implicated in the expression of nociception elicited by i.t. injection of either NMDA or (+)TAN-67 in the mouse.",
author = "Yoshinori Yajima and Minoru Narita and Makoto Tsuda and Satoshi Imai and Junzo Kamei and Hiroshi Nagase and Tsutomu Suzuki",
year = "2000",
month = "12",
day = "29",
doi = "10.1016/S0024-3205(00)00975-9",
language = "English",
volume = "68",
pages = "719--725",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Modulation of NMDA- and (+)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord

AU - Yajima, Yoshinori

AU - Narita, Minoru

AU - Tsuda, Makoto

AU - Imai, Satoshi

AU - Kamei, Junzo

AU - Nagase, Hiroshi

AU - Suzuki, Tsutomu

PY - 2000/12/29

Y1 - 2000/12/29

N2 - The present study was designed to investigate the effect of a selective GABAB receptor agonist baclofen on the pain-like nociceptive behavior (scratching, biting and licking) induced by intrathecal (i.t.) injection of N-methyl-D-aspartate (NMDA) or (+)TAN-67, the enantiomorphs of 2-methyl-4aα-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12aα-octahydro-qui nolino[2,3,3g]isoquinoline (TAN-67), in the mouse. NMDA (0.05-0.2 μg/mouse) given i.t. immediately caused nociception in a dose-dependent manner. The nociception was significantly antagonized by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse), a non-competitive NMDA receptor antagonist. I.t. co-injection with baclofen (37.5-150 ng/mouse) significantly reduced the NMDA-induced nociceptive behavior in a dose-dependent fashion. The inhibition produced by baclofen was completely reversed by a selective GABAB receptor antagonist 2-hydroxysaclofen (0.15 and 0.3 μg/mouse). An i.t. injection of (+)TAN-67 at doses of 3.75-15 μg/mouse elicited a long-lasting and a dose-related nociception. The nociceptive behavior induced by (+)TAN-67 given i.t. was markedly suppressed by i.t. co-injection with baclofen (3-30 ng/mouse), and the inhibitory effect of baclofen was prevented by i.t. injection of 2-hydroxysaclofen (1 and 3 μg/mouse). In addition, the (+)TAN-67-induced nociception was also attenuated by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse). These results suggest that spinal GABAB receptors may be implicated in the expression of nociception elicited by i.t. injection of either NMDA or (+)TAN-67 in the mouse.

AB - The present study was designed to investigate the effect of a selective GABAB receptor agonist baclofen on the pain-like nociceptive behavior (scratching, biting and licking) induced by intrathecal (i.t.) injection of N-methyl-D-aspartate (NMDA) or (+)TAN-67, the enantiomorphs of 2-methyl-4aα-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12aα-octahydro-qui nolino[2,3,3g]isoquinoline (TAN-67), in the mouse. NMDA (0.05-0.2 μg/mouse) given i.t. immediately caused nociception in a dose-dependent manner. The nociception was significantly antagonized by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse), a non-competitive NMDA receptor antagonist. I.t. co-injection with baclofen (37.5-150 ng/mouse) significantly reduced the NMDA-induced nociceptive behavior in a dose-dependent fashion. The inhibition produced by baclofen was completely reversed by a selective GABAB receptor antagonist 2-hydroxysaclofen (0.15 and 0.3 μg/mouse). An i.t. injection of (+)TAN-67 at doses of 3.75-15 μg/mouse elicited a long-lasting and a dose-related nociception. The nociceptive behavior induced by (+)TAN-67 given i.t. was markedly suppressed by i.t. co-injection with baclofen (3-30 ng/mouse), and the inhibitory effect of baclofen was prevented by i.t. injection of 2-hydroxysaclofen (1 and 3 μg/mouse). In addition, the (+)TAN-67-induced nociception was also attenuated by i.t. co-injection with dizocilipine (0.1-1.0 μg/mouse). These results suggest that spinal GABAB receptors may be implicated in the expression of nociception elicited by i.t. injection of either NMDA or (+)TAN-67 in the mouse.

UR - http://www.scopus.com/inward/record.url?scp=0034731284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034731284&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(00)00975-9

DO - 10.1016/S0024-3205(00)00975-9

M3 - Article

C2 - 11205886

AN - SCOPUS:0034731284

VL - 68

SP - 719

EP - 725

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 6

ER -